Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Multidisciplinary approach for risk-oriented treatment of low-risk papillary thyroid cancer in Switzerland.

Zulewski H, Giovanella L, Bilz S, Christ E, Haldemann A, Steinert H, Weidner S, Oertli D, Triponez F, Clerici T, Minder A, Dettmer M, Komminoth P.

Swiss Med Wkly. 2019 Jan 27;149:w14700. doi: 10.4414/smw.2019.14700. eCollection 2019 Jan 14. No abstract available.

2.

[Diagnosis and Treatment of Familial Hypercholesterolemia].

Schöb M, Müller P, Gerth Y, Korte W, Rickli H, Brändle M, Bärlocher A, Bilz S.

Praxis (Bern 1994). 2018 Nov;107(24):1345-1353. doi: 10.1024/1661-8157/a003134. Review. German.

PMID:
30482120
3.

Comparison of the dose-response pharmacodynamic profiles of detemir and glargine in severely obese patients with type 2 diabetes: A single-blind, randomised cross-over trial.

Bilz S, Flückiger M, Meienberg F, Falconnier C, Keller U, Puder JJ.

PLoS One. 2018 Aug 16;13(8):e0202007. doi: 10.1371/journal.pone.0202007. eCollection 2018.

4.

A Copeptin-Based Approach in the Diagnosis of Diabetes Insipidus.

Fenske W, Refardt J, Chifu I, Schnyder I, Winzeler B, Drummond J, Ribeiro-Oliveira A Jr, Drescher T, Bilz S, Vogt DR, Malzahn U, Kroiss M, Christ E, Henzen C, Fischli S, Tönjes A, Mueller B, Schopohl J, Flitsch J, Brabant G, Fassnacht M, Christ-Crain M.

N Engl J Med. 2018 Aug 2;379(5):428-439. doi: 10.1056/NEJMoa1803760.

5.

Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.

Hornemann T, Alecu I, Hagenbuch N, Zhakupova A, Cremonesi A, Gautschi M, Jung HH, Meienberg F, Bilz S, Christ E, Baumgartner MR, Hochuli M.

Mol Genet Metab. 2018 Sep;125(1-2):73-78. doi: 10.1016/j.ymgme.2018.07.003. Epub 2018 Jul 20.

PMID:
30037504
6.

Bedeutung und Therapie der Dyslipidämie beim Diabetes.

Bilz S.

Ther Umsch. 2017;74(8):445-453. doi: 10.1024/0040-5930/a000939. Review. German. No abstract available.

PMID:
29461147
7.

A rare case of an ACTH/CRH co-secreting midgut neuroendocrine tumor mimicking Cushing's disease.

Streuli R, Krull I, Brändle M, Kolb W, Stalla G, Theodoropoulou M, Enzler-Tschudy A, Bilz S.

Endocrinol Diabetes Metab Case Rep. 2017 Jun 16;2017. pii: 17-0058. doi: 10.1530/EDM-17-0058. eCollection 2017.

8.

A 37-year-old Menkes disease patient-Residual ATP7A activity and early copper administration as key factors in beneficial treatment.

Tümer Z, Petris M, Zhu S, Mercer J, Bukrinski J, Bilz S, Baerlocher K, Horn N, Møller LB.

Clin Genet. 2017 Nov;92(5):548-553. doi: 10.1111/cge.13083.

PMID:
28657131
9.

Rapid Onset of Diabetic Ketoacidosis After SGLT2 Inhibition in a Patient With Unrecognized Acromegaly.

Quarella M, Walser D, Brändle M, Fournier JY, Bilz S.

J Clin Endocrinol Metab. 2017 May 1;102(5):1451-1453. doi: 10.1210/jc.2017-00082.

PMID:
28323955
10.

Interleukin-1 antagonism in type 1 diabetes of long duration.

Seelig E, Timper K, Falconnier C, Stoeckli R, Bilz S, Oram R, McDonald TJ, Donath MY.

Diabetes Metab. 2016 Dec;42(6):453-456. doi: 10.1016/j.diabet.2016.08.005. Epub 2016 Oct 5. No abstract available.

PMID:
27720360
11.

Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?

Grouzmann E, Tschopp O, Triponez F, Matter M, Bilz S, Brändle M, Drechser T, Sigrist S, Zulewski H, Henzen C, Fischli S, Abid K.

PLoS One. 2015 May 6;10(5):e0125426. doi: 10.1371/journal.pone.0125426. eCollection 2015.

12.

Impact of clinical risk scores and BRAF V600E mutation status on outcome in papillary thyroid cancer.

Niederer-Wüst SM, Jochum W, Förbs D, Brändle M, Bilz S, Clerici T, Oettli R, Müller J, Haile SR, Ess S, Stoeckli SJ, Broglie MA.

Surgery. 2015 Jan;157(1):119-25. doi: 10.1016/j.surg.2014.07.015.

PMID:
25482468
13.

Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP <232>/<233>.

Fischer L, Zipfel B, Koellensperger G, Kovac J, Bilz S, Kunkel A, Venzago C, Hann S.

J Pharm Biomed Anal. 2014 Jul;95:121-9. doi: 10.1016/j.jpba.2014.02.016. Epub 2014 Mar 3.

PMID:
24667566
14.

Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awareness.

Seelig E, Bilz S, Keller U, Meienberg F, Christ-Crain M.

PLoS One. 2013 Aug 30;8(8):e72876. doi: 10.1371/journal.pone.0072876. eCollection 2013.

15.

Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study.

Seelig E, Keller U, Klarhöfer M, Scheffler K, Brand S, Holsboer-Trachsler E, Hatzinger M, Bilz S.

PLoS One. 2013 Apr 12;8(4):e61780. doi: 10.1371/journal.pone.0061780. Print 2013.

16.

Monoamine oxidase A down-regulation contributes to high metanephrine concentration in pheochromocytoma.

Grouzmann E, Matter M, Bilz S, Herren A, Triponez F, Henzen C, Kim KS, Zulewski H, Buclin T, Brakch N, Abid K.

J Clin Endocrinol Metab. 2012 Aug;97(8):2773-81. doi: 10.1210/jc.2012-1557. Epub 2012 May 8.

PMID:
22569243
17.

Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus.

Engler B, Koehler C, Hoffmann C, Landgraf W, Bilz S, Schoner C, Bornstein SR, Hanefeld M.

Exp Clin Endocrinol Diabetes. 2011 Jan;119(1):59-61. doi: 10.1055/s-0030-1262874. Epub 2011 Jan 18.

PMID:
21246466
18.

[Craniopharyngioma--a "geographical malignant" tumour].

Stienen MN, Cadosch D, Bilz S, Hildebrandt G, Gautschi OP.

Praxis (Bern 1994). 2010 Jul 28;99(15):911-21. doi: 10.1024/1661-8157/a000202. Review. German.

PMID:
20715005
19.

Cerebral edema and intracranial hypertension in an adult with maple syrup urine disease.

Sutter R, Killer HE, Bilz S, Baumgartner M, Ott HW, Steck AJ, Renaud S.

Eur J Neurol. 2009 Mar;16(3):e45-6. doi: 10.1111/j.1468-1331.2008.02425.x. No abstract available.

PMID:
19364339
20.

Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat-induced insulin resistance in skeletal muscle.

Morino K, Neschen S, Bilz S, Sono S, Tsirigotis D, Reznick RM, Moore I, Nagai Y, Samuel V, Sebastian D, White M, Philbrick W, Shulman GI.

Diabetes. 2008 Oct;57(10):2644-51. doi: 10.2337/db06-0454. Epub 2008 Jul 15.

21.

[Hypertension and hyperhidrosis. Pheochromocytoma].

Mettler J, Battegay E, Egelhof T, Oertli D, Zimmerli L, Bilz S.

Praxis (Bern 1994). 2008 Jan 23;97(2):73-6. German.

PMID:
18303664
22.

The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.

Petersen KF, Dufour S, Savage DB, Bilz S, Solomon G, Yonemitsu S, Cline GW, Befroy D, Zemany L, Kahn BB, Papademetris X, Rothman DL, Shulman GI.

Proc Natl Acad Sci U S A. 2007 Jul 31;104(31):12587-94. Epub 2007 Jul 18.

23.

Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome.

Conen D, Melly L, Kaufmann C, Bilz S, Ammann P, Schaer B, Sticherling C, Muller B, Osswald S.

J Am Coll Cardiol. 2007 Jun 19;49(24):2350-5. Epub 2007 Jun 4.

24.

Women with polycystic ovary syndrome are sensitive to the TNF-alpha-lowering effect of glucose-induced hyperinsulinaemia.

Puder JJ, Varga S, Nusbaumer CP, Zulewski H, Bilz S, Müller B, Keller U.

Eur J Clin Invest. 2006 Dec;36(12):883-9.

PMID:
17087783
25.

Coregistered iodine-131 single photon emission computed tomography/computed tomography reveals dedifferentiation in a metastatic follicular thyroid carcinoma.

Walter MA, Wild D, Rasch H, Müller-Brand J, Müller B, Bilz S.

Thyroid. 2006 Oct;16(10):1063-4. No abstract available.

PMID:
17042695
26.

Effect of gastric bypass and gastric banding on proneurotensin levels in morbidly obese patients.

Christ-Crain M, Stoeckli R, Ernst A, Morgenthaler NG, Bilz S, Korbonits M, Struck J, Bergmann A, Müller B, Keller U.

J Clin Endocrinol Metab. 2006 Sep;91(9):3544-7. Epub 2006 Jun 20.

PMID:
16787986
27.

Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters.

Bilz S, Samuel V, Morino K, Savage D, Choi CS, Shulman GI.

Am J Physiol Endocrinol Metab. 2006 Apr;290(4):E716-22. Epub 2005 Nov 15.

28.

Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents.

Morino K, Petersen KF, Dufour S, Befroy D, Frattini J, Shatzkes N, Neschen S, White MF, Bilz S, Sono S, Pypaert M, Shulman GI.

J Clin Invest. 2005 Dec;115(12):3587-93. Epub 2005 Nov 10.

29.

Changes in bone mineral content after surgical treatment of morbid obesity.

von Mach MA, Stoeckli R, Bilz S, Kraenzlin M, Langer I, Keller U.

Metabolism. 2004 Jul;53(7):918-21.

PMID:
15254887
30.

Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.

Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, Shulman GI.

J Biol Chem. 2004 Jul 30;279(31):32345-53. Epub 2004 May 27.

31.

Effects of changes in hydration on protein, glucose and lipid metabolism in man: impact on health.

Keller U, Szinnai G, Bilz S, Berneis K.

Eur J Clin Nutr. 2003 Dec;57 Suppl 2:S69-74.

PMID:
14681716
32.

Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia.

Bilz S, Wagner S, Schmitz M, Bedynek A, Keller U, Demant T.

J Lipid Res. 2004 Jan;45(1):174-85. Epub 2003 Oct 1.

33.

Effects of medium- and long-chain fatty acids on whole body leucine and glucose kinetics in man.

Keller U, Turkalj I, Laager R, Bloesch D, Bilz S.

Metabolism. 2002 Jun;51(6):754-60.

PMID:
12037730
34.

Nutritional supplements combined with dietary counselling diminish whole body protein catabolism in HIV-infected patients.

Berneis K, Battegay M, Bassetti S, Nuesch R, Leisibach A, Bilz S, Keller U.

Eur J Clin Invest. 2000 Jan;30(1):87-94.

PMID:
10620007
35.

[Polycystic ovary syndrome--only relevant in reproductive medicine?].

Heim SC, De Geyter C, Siegrist W, Bilz S, Keller U.

Ther Umsch. 1999 May;56(5):271-5. Review. German.

PMID:
10409902
36.

Effects of hypoosmolality on whole-body lipolysis in man.

Bilz S, Ninnis R, Keller U.

Metabolism. 1999 Apr;48(4):472-6.

PMID:
10206440

Supplemental Content

Support Center